Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) Prospective Double-Scanning Study
ConditionSPECT-CT
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorGE Healthcare
About this trial
The goal of this study is to collect image data for the StarGuide GX Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) System in a clinical setting. The StarGuide GX scan will be compared to the participant's clinically indicated SPECT/CT scanner.
Eligibility criteria
Qualifiers
Adult, who is at least 18 years of age, on day of consent.
Must have a clinically indicated SPECT/CT exam scheduled according to current clinical practice standards; AND
Able and willing to provide informed consent for participation in this study.
Disqualifiers
Who, per the site's Standard Operating Procedures (SOPs), has any condition that would prevent the clinically indicated SPECT/CT from proceeding (i.e., pregnancy, breastfeeding, renal impairment, etc.);
Who were previously enrolled in this study;
Who need urgent or emergent care;
Who have any conditions that, in the opinion of the Principal Investigator (PI) or designee, would interfere with the evaluation of the results, or constitute a health hazard for the participant;
Trial design
Treatments tested in this trial
- StarGuide GX SPECT/CT Scan
Treatment groups
30 Participants
are divided into 1 treatment groupSponsors and collaborators
GE Healthcare
Lead sponsor
Rambam Health Care Campus
Collaborator
Source ClinicalTrials.gov